# Hikma Pharmaceuticals USA, Inc.: Ifosfamide Injection new FDA shortage listing (unavailable from this maker)

**Score:** 85/100

| Field | Value |
|---|---|
| Manufacturer | Hikma Pharmaceuticals USA, Inc. |
| Drug | Ifosfamide Injection |
| Dosage form | Injection |
| Therapeutic category | Oncology, Pediatric |
| Status | Current |
| Stage | New shortage posted |
| Availability | Unavailable |
| Reason | Demand increase for the drug |
| Presentations affected | 2 |
| Package NDCs | 0143-9531-01, 0143-9530-01 |
| Manufacturer supply note | Additional lots will be available in the November 2026 timeframe. Product will be made available as it is released. |
| First posted | 2026-06-12 |
| Updated | 2026-10-14 |

## Why this score
- Newly posted shortage: buyers are looking for another source now.
- Unavailable from this manufacturer.
- Sterile injectable: hospital and 503B demand.

Source: openFDA drug shortages endpoint (U.S. Food and Drug Administration drug shortage list) (https://dps.fda.gov/drugshortages). Last refreshed: 2026-11-04T06:10:12.565Z.
From the openFDA drug shortages endpoint, which mirrors the FDA drug shortage list and can lag it by days. Availability and recovery notes are the manufacturer's own statements to FDA. Company and product level only. Verify with FDA and the manufacturer before acting.